U2CDA050098 (Q31753): Difference between revisions

@@ Property / instance of @@
+grant
@@ Property / instance of: grant / rank @@
+Normal rank
@@ Property / instance of: grant / reference @@
+stated in: PubMed
@@ Property / grant identifier @@
+U2C DA050098
@@ Property / grant identifier: U2C DA050098 / rank @@
+Normal rank
@@ Property / grant identifier: U2C DA050098 / reference @@
+stated in: PubMed
@@ Property / institute code @@
+DA
@@ Property / institute code: DA / rank @@
+Normal rank
@@ Property / institute code: DA / reference @@
+stated in: PubMed
@@ Property / serial number @@
@@ Property / serial number: 050098 / rank @@
+Normal rank
@@ Property / serial number: 050098 / reference @@
+stated in: PubMed
@@ Property / funder @@
+National Institute on Drug Abuse
@@ Property / funder: National Institute on Drug Abuse / rank @@
+Normal rank
@@ Property / funder: National Institute on Drug Abuse / reference @@
+stated in: PubMed
@@ Property / primary funding institute or center @@
+National Institute on Drug Abuse
+Normal rank
+stated in: PubMed
@@ Property / country of origin @@
+United States of America
@@ Property / country of origin: United States of America / rank @@
+Normal rank
@@ Property / country of origin: United States of America / reference @@
+stated in: PubMed

Latest revision as of 01:10, 14 November 2024